CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
The objective of DIAGNODE-3 is to evaluate the efficacy and safety of three intranodal injections of 4 μg of Diamyd compared to placebo, along with o...
Phase 3
•Valencia, Spain and 59 other locations
States, where 2 out of 3 non-traumatic amputations derive from diabetes. This is why the main objective of this project is to establish a st...
Valencia, Spain
This is a multicenter, randomized, placebo-controlled, 2-part study to evaluate the safety and efficacy of AT-001 in adult patients (N=675) with Diabetic...
Phase 3
•Valencia, Spain and 78 other locations
This study will look at the long-term effects of semaglutide (active medicine) on diabetic eye disease when compared to placebo (dummy medic...
Phase 3
•Valencia, Spain and 177 other locations
The purpose of the trial is to assess the efficacy and safety of tirzepatide to dulaglutide in participants with type 2 diabetes and increas...
Phase 3
•València, Spain and 654 other locations
the effect of retatrutide on renal function in participants with overweight or obesity and chronic kidney disease (CKD), with or without Type 2 Diabetes...
Phase 2
•Valencia, Valenciana, Comunitat, Spain and 41 other locations
This study will look if CagriSema can lower kidney damage in people with chronic kidney disease (CKD), type 2 diabetes (T2D) and overweight ...
Phase 2
•Valencia, Spain and 125 other locations
The main purpose of this study is to determine safety and efficacy of orforglipron compared with insulin glargine in participants with type 2 diabetes...
Phase 3
•Alzira, Valenciana, Comunitat, Spain and 392 other locations
will be done in participants who have type 2 diabetes. Participants will take the study medicine together with the current diabetes...
Phase 3
•Valencia, Spain and 347 other locations
of vamikibart administered intravitreally in participants with diabetic macular edema. Only one eye will be chosen as the study eye. The dur...
Phase 2
•Burjassot, Valencia, Spain and 69 other locations
Clinical trials
Research sites
Resources
Legal